Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Ketotifen

An antihistamine and mast cell stabiliser developed in Switzerland, patented in 1970 and in use since 1976: it is used to prevent asthma and allergies and, as eye drops, for allergic conjunctivitis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It is almost a twin of pizotifen, a medicine used for migraine: the two molecules differ only by a ketone group (C=O), present in ketotifen.

KetotifenGo to the active ingredient →
KetotifenActive ingredientKetotifenCat. No. P-K009-001CAS 34580-13-7

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.